BOC Healthcare is reliable, flexible, and responsive to its customer’s needs. A pioneer in technology, innovation and inventiveness, BOC Healthcare works tirelessly to design and engineer products that enhance patient care and meet the unique needs of healthcare professionals. We have been instrumental in developing and introducing many important innovations to support its customers including:
The lightweight integral valve cylinder
ENTONOX® (nitrous oxide/oxygen mixture) for pain relief in painful procedures and for mothers during childbirth.
HELIOX21 medical gas mixture to ease the work of breathing in acute respiratory distress.
Nitric oxide to improve oxygenation in newborns suffering from hypoxic respiratory failure*.
We are taking a more active role than ever in patient care, and developing superior products for the best clinical outcomes. Our investment in Research and Development continues, as does our search for new service innovations that add real value for our customers.
BOC Healthcare is a major exponent of medical research in the UK, supporting studies undertaken by the British Lung Foundation, sponsoring the chair of anaesthesia at Southampton university, as well as managing a major trial of HELIOX21 at St Mary’s hospital, Paddington in London.
Through the Linde Group REALfund programme we continue to support research by clinicians and academic institutions in several clinical areas in the pursuit of therapeutic solutions for optimising patient care and outcomes.